Made in France must also shine in health. And Frédéric Girard intends to ensure this. Just before the summer, the man took the reins of France Biotech, which brings together healthtechs. Founded in 1997 to promote French medical innovation, this association currently has ten employees, an annual budget of 2 million euros and 700 members, “representing all product families, from medicines to digital health solutions”, says the man who is also vice-president of the allergy specialist DBV Technologies.
In addition to the reluctance of investors, the 58-year-old manager, with his chiseled words and jade-like gaze, cites, among “key subjects”, regulatory developments, talent recruitment and international development.
